phosphorylethanolamine has been researched along with sulbactam in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Doi, Y; Ernst, RK; Hittle, LE; O'Hara, JA; Pasculle, AW; Qureshi, ZA; Rivera, JI; Shields, RK; Syed, A | 1 |
Abe, S; Badavath, VN; Chatsuwan, T; Gan, L; Higgins, PG; Hongsing, P; Hurst, C; Kueakulpattana, N; Kupwiwat, R; Leelahavanichkul, A; Liao, T; Luk-In, S; Phattharapornjaroen, P; Saethang, T; Shein, AMS; Srisakul, S; Tanasatitchai, C; Wannigama, DL; Wapeesittipan, P | 1 |
2 other study(ies) available for phosphorylethanolamine and sulbactam
Article | Year |
---|---|
Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Ampicillin; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Electronic Health Records; Electrophoresis, Gel, Pulsed-Field; Ethanolamines; Female; Humans; Lipid A; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Pneumonia, Ventilator-Associated; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sulbactam | 2015 |
Overcoming addition of phosphoethanolamine to lipid A mediated colistin resistance in Acinetobacter baumannii clinical isolates with colistin-sulbactam combination therapy.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Colistin; Ethanolamines; Humans; Lipid A; Microbial Sensitivity Tests; Phosphatidylethanolamines; Sulbactam | 2022 |